Electrocardiographic P-wave characteristics in patients with psoriasis vulgaris

References

• Schön MP, Boehncke WH. Psoriasis. N Engl J Med. 2005;352:1899–912.
   PubMed Web of Science ®Google Scholar
• Rosa DJ, Machado RF, Matias FA, Cedrim SD, Noronha FL, Gaburri D, Influence of severity of the cutaneous manifestations and age on the prevalence of several cardiovascular risk factors in patients with psoriasis. J Eur Acad Dermatol Venereol. 2012;26:348–53.
   PubMed Web of Science ®Google Scholar
• Markuszeski L, Bissinger A, Janusz I, Narbutt J, Jedrzejowska AS, Zalewska A. Heart rate and arrhythmia in patients with psoriasis vulgaris. Arch Med Res. 2007;38:64–9.
   PubMed Web of Science ®Google Scholar
• Ahlehoff O, Gislason GH, Jørgensen CH, Lindhardsen J, Charlot M, Olesen JB, Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J. 2012;33:2054–64.
   PubMed Web of Science ®Google Scholar
• Centurion OA. Clinical implications of the P wave duration and dispersion: relationship between atrial conduction defects and abnormally prolonged and fractionated atrial endocardial electrograms. Int J Cardiol. 2009;134:6–8.
   PubMed Web of Science ®Google Scholar
• Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998;135:733–8.
   PubMed Web of Science ®Google Scholar
• Dogdu O, Yarlioglues M, Kaya MG, Ardic I, Kilinc Y, Elcik D, Assessment of atrial conduction time in patients with systemic lupus erythematosus. J Investig Med. 2011;59:281–6.
   PubMed Web of Science ®Google Scholar
• Acar G, Akcay A, Sayarlioglu M, Sokmen A, Sokmen G, Koroglu S, Assessment of atrial conduction time in patients with familial Mediterranean fever. Pacing Clin Electrophysiol. 2009;32:308–13.
   PubMed Web of Science ®Google Scholar
• Louden BA, Pearce DJ, Lang W, Feldman SR. A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J. 2004;10:7.
   PubMedGoogle Scholar
• Amornpinyokeit N, Asawanonda P. 8-Methoxypsoralen cream plus targeted narrowband ultraviolet B for psoriasis. Photodermatol Photoimmunol Photomed. 2006;22:285–9.
   PubMed Web of Science ®Google Scholar
• Rich P, Scher RK. Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003;49:206–12.
   PubMed Web of Science ®Google Scholar
• Michelucci A, Bagliani G, Colella A, Pieragnoli P, Porciani MC, Gensini G, P wave assessment: state of the art update. Card Electrophysiol Rev. 2002;6:215–20.
   PubMedGoogle Scholar
• Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.
   PubMed Web of Science ®Google Scholar
• Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol. 2009;145:700–3.
   PubMed Web of Science ®Google Scholar
• Rico T, Marchione R, Kirsner RS. Vascular disease in psoriasis. J Invest Dermatol. 2009;129:2327.
   PubMed Web of Science ®Google Scholar
• Flammer AJ, Ruschitzka F. Psoriasis and atherosclerosis: two plaques, one syndrome? Eur Heart J. 2012;33:1989–91.
   PubMed Web of Science ®Google Scholar
• Patel RV, Shelling ML, Prodanovich S, Federman DG, Kirsner RS. Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literature. J Gen Intern Med. 2011;26:1036–49.
   PubMed Web of Science ®Google Scholar
• Daudén E, Castañeda S, Suárez C, García-Campayo J, Blasco AJ, Aguilar MD, et al. [Integrated approach to comorbidity in patients with psoriasis]. Actas Dermosifiliogr. 2012;103:1–64.
   PubMedGoogle Scholar
• Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296:1735–41.
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Dommasch ED, Shin DB, Azfar RS, Kurd SK, Wang X, The risk of stroke in patients with psoriasis. J Invest Dermatol. 2009;129:2411–18.
   PubMed Web of Science ®Google Scholar
• Brauchli YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case–control analysis. Br J Dermatol. 2009;160:1048–56.
   PubMed Web of Science ®Google Scholar
• Kimball AB, Guerin A, Latremouille-Viau D, Yu AP, Gupta S, Bao Y, Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis. Am J Med. 2010;123:350–7.
   PubMed Web of Science ®Google Scholar
• Shiber JR, Fontane E, Adewale A. Stroke registry: hemorrhagic vs ischemic strokes. Am J Emerg Med. 2010;28:331–3.
   PubMed Web of Science ®Google Scholar
• Go AS. The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg. Am J Geriatr Cardiol. 2005;14:56–61.
   PubMedGoogle Scholar
• Akturk E, Yağmur J, Açıkgöz N, Ermiş N, Cansel M, Karakuş Y, Assessment of atrial conduction time by tissue Doppler echocardiography and P-wave dispersion in smokers. J Interv Card Electrophysiol. 2012;34:247–53.
   PubMed Web of Science ®Google Scholar
• Yagmur J, Yetkin O, Cansel M, Acikgoz N, Ermis N, Karakus Y, Assessment of atrial electromechanical delay and influential factors in patients with obstructive sleep apnea. Sleep Breath. 2012;16:83–8.
   PubMed Web of Science ®Google Scholar
• Yasar AS, Bilen E, Bilge M, Ipek G, Ipek E, Kirbas O. P-wave duration and dispersion in patients with metabolic syndrome. Pacing Clin Electrophysiol. 2009;32:1168–72.
   PubMed Web of Science ®Google Scholar
• Celik T, Yuksel UC, Bugan B, Celik M, Fici F, Iyisoy A, P-wave dispersion and its relationship to aortic elasticity in young prehypertensive patients. Am J Hypertens. 2009;22:1270–5.
   PubMed Web of Science ®Google Scholar